Implementation of Failure Mode and Effects Analysis to the specimens flow in a population-based colorectal cancer screening programme using immunochemical faecal occult blood tests: a quality improvement project in the Milan colorectal cancer screening programme
- PMID: 29610774
- PMCID: PMC5878255
- DOI: 10.1136/bmjoq-2017-000299
Implementation of Failure Mode and Effects Analysis to the specimens flow in a population-based colorectal cancer screening programme using immunochemical faecal occult blood tests: a quality improvement project in the Milan colorectal cancer screening programme
Abstract
Background: A multidisciplinary working group applied the Healthcare Failure Mode and Effects Analysis (HFMEA) approach to the flow of kits and specimens for the first-level test of a colorectal cancer screening programme using immunochemical faecal occult blood tests.
Methods: HFMEA comprised four steps: (1) identification and mapping of the process steps (subprocesses); (2) analysis of failure modes and calculation of the risk priority numbers (RPNs); (3) identification of corrective actions; and (4) follow-up and evaluation of corrective actions.
Results: The team identified 9 main failure modes, 12 effects and 34 associated causes. RPN scores ranged from 2 to 96. Failure modes within the first five positions in the ranking list ordered by RPN concerned: 'degraded haemoglobin in the specimen', 'mixed-up kits' and 'anonymous specimen'. All of these could lead to false-negative results and/or subjects with positive tests not being recalled for assessment. The team planned corrective actions for those failure modes. As a result, the follow-up of corrective actions showed a significant decrease in the proportion of anonymous kits from 11.6 to 4.8 per 1000 (relative reduction of 59%). The HFMEA exercise led to a reduction in: missed positive tests; missed cancer and high-risk adenomas; complaints about the communication of test results to a person who never did the test; and false-negative results due either to haemoglobin degradation or an expired sampling tube.
Conclusions: HFMEA is a useful tool for reducing errors in colorectal cancer screening programmes using faecal occult blood tests and is characterised by a straightforward interpretation of results and ease of communication to healthcare managers and decision makers.
Keywords: failure modes and effects analysis (fmea); healthcare quality improvement; quality improvement.
Conflict of interest statement
Competing interests: None declared.
Figures
References
-
- Cohen MR, Senders J, Davis NM. Failure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidents. Hosp Pharm 1994;29:319–30. - PubMed
-
- McDermott RE, Mikulak RJ, Beauregard MR. The basics of FMEA. New York: Productivity, Inc, 1996.
-
- DeRosier J, Stalhandske E, Bagian JP, et al. Using health care failure mode and effect analysis: the va national center for patient safety’s prospective risk analysis system. Jt Comm J Qual Improv 2002;28:248–67. - PubMed
-
- Joint Commission international. Hospital accreditation standards. 2nd edn Chicago, 2001.
-
- Giardina M, Cantone MC, Tomarchio E, et al. A review of healthcare failure mode and effects analysis (hfmea) in radiotherapy. Health Phys 2016;111:317–26. doi:10.1097/HP.0000000000000536 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials